Cargando…

Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?

Endothelial cell dysfunction and impaired microcirculatory function contribute markedly to life-threatening complications of COVID-19, such as venous thromboembolic disease and multiple organ involvement https://bit.ly/3cZMjKV

Detalles Bibliográficos
Autores principales:	Huertas, Alice, Montani, David, Savale, Laurent, Pichon, Jérémie, Tu, Ly, Parent, Florence, Guignabert, Christophe, Humbert, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2020
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301835/ https://www.ncbi.nlm.nih.gov/pubmed/32554538 http://dx.doi.org/10.1183/13993003.01634-2020

Ejemplares similares

Precision medicine and personalising therapy in pulmonary hypertension: seeing the light from the dawn of a new era
por: Savale, Laurent, et al.
Publicado: (2018)

Pathogenesis of pulmonary arterial hypertension: lessons from cancer
por: Guignabert, Christophe, et al.
Publicado: (2013)

A rare case of sarcoidosis-associated pulmonary hypertension in a patient exposed to silica
por: Bourlier, Delphine, et al.
Publicado: (2016)

Screening for pulmonary arterial hypertension in adults carrying a BMPR2 mutation
por: Montani, David, et al.
Publicado: (2021)

Purinergic Dysfunction in Pulmonary Arterial Hypertension
por: Cai, Zongye, et al.
Publicado: (2020)

An endothelial activin A-bone morphogenetic protein receptor type 2 link is overdriven in pulmonary hypertension
por: Ryanto, Gusty R. T., et al.
Publicado: (2021)

N-acetylcysteine improves established monocrotaline-induced pulmonary hypertension in rats
por: Chaumais, Marie-Camille, et al.
Publicado: (2014)

Sequential combination therapy with parenteral prostacyclin in BMPR2 mutations carriers
por: Boucly, Athénaïs, et al.
Publicado: (2022)

Screening for pulmonary arterial hypertension in systemic sclerosis
por: Weatherald, Jason, et al.
Publicado: (2019)

Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission
por: Jevnikar, Mitja, et al.
Publicado: (2021)

Pulmonary Hypertension Complicating Fibrosing Mediastinitis
por: Seferian, Andrei, et al.
Publicado: (2015)

Macrophage Migration Inhibitory Factor (MIF) Inhibition in a Murine Model of Bleomycin-Induced Pulmonary Fibrosis
por: Günther, Sven, et al.
Publicado: (2018)

Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?
por: Weatherald, Jason, et al.
Publicado: (2021)

Reply to Jin et al. and to Sun et al.
por: Boucly, Athénaïs, et al.
Publicado: (2021)

Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation
por: Beurnier, Antoine, et al.
Publicado: (2020)

Multidisciplinary approach for post-acute COVID-19 syndrome: time to break down the walls
por: Montani, David, et al.
Publicado: (2021)

Identifying new drugs associated with pulmonary arterial hypertension: A WHO pharmacovigilance database disproportionality analysis
por: Hlavaty, Alex, et al.
Publicado: (2022)

Different cardiovascular and pulmonary phenotypes for single- and double-knock-out mice deficient in BMP9 and BMP10
por: Bouvard, Claire, et al.
Publicado: (2021)

Factors predicting outcome after pulmonary endarterectomy
por: Tromeur, Cécile, et al.
Publicado: (2018)

Pulmonary hypertension associated with neurofibromatosis type 2
por: Taniguchi, Hirohisa, et al.
Publicado: (2021)

French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
por: Brenot, Philippe, et al.
Publicado: (2019)

Pulmonary hypertension associated with busulfan
por: Hagenburg, Jean, et al.
Publicado: (2021)

Pulmonary hypertension associated with neurofibromatosis type 1
por: Jutant, Etienne-Marie, et al.
Publicado: (2018)

Endothelial dysfunction and hypercoagulability in severe sickle-cell acute chest syndrome
por: Jutant, Etienne-Marie, et al.
Publicado: (2021)

Rapid onset honeycombing fibrosis in spontaneously breathing patient with COVID-19
por: Combet, Margot, et al.
Publicado: (2020)

Preventing the Increase in Lysophosphatidic Acids: A New Therapeutic Target in Pulmonary Hypertension?
por: Duflot, Thomas, et al.
Publicado: (2021)

Acute decompensated pulmonary hypertension
por: Savale, Laurent, et al.
Publicado: (2017)

Exosomes: Potential Player in Endothelial Dysfunction in Cardiovascular Disease
por: Nikdoust, Farahnaz, et al.
Publicado: (2021)

Functional respiratory complaints among COVID-19 survivors: a prospective cohort study
por: Beurnier, Antoine, et al.
Publicado: (2023)

The quiescent endothelium: signalling pathways regulating organ-specific endothelial normalcy
por: Ricard, Nicolas, et al.
Publicado: (2021)

Endothelial cells are major players in SARS-CoV-2-related acute respiratory distress syndrome
por: Caccuri, Francesca, et al.
Publicado: (2022)

Vitamin D: a novel player in endothelial function and dysfunction
por: Caprio, Massimiliano, et al.
Publicado: (2012)

Respiratory symptoms and radiological findings in post-acute COVID-19 syndrome
por: Jutant, Etienne-Marie, et al.
Publicado: (2022)

Efficacy of immunosuppressants with bridge vasodilator therapy in severe lupus erythematosus‐associated pulmonary arterial hypertension
por: Sanges, Sébastien, et al.
Publicado: (2019)

The isobaric pulmonary arterial compliance in pulmonary hypertension
por: Chemla, Denis, et al.
Publicado: (2021)

Editorial: Molecular Mechanisms in Pulmonary Hypertension and Right Ventricle Dysfunction
por: Karmouty-Quintana, Harry, et al.
Publicado: (2018)

Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission and role for pre-test probability scores and home treatment
por: Jevnikar, Mitja, et al.
Publicado: (2021)

Pulmonary arterial hypertension
por: Montani, David, et al.
Publicado: (2013)

Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice
por: Savale, Laurent, et al.
Publicado: (2009)

Seeing the Forest for the (Arterial) Tree: Vascular Pruning and the Chronic Obstructive Pulmonary Disease Pulmonary Vascular Phenotype
por: Weatherald, Jason, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qed67c19cbj0irhks8pt1jqshl